Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer
暂无分享,去创建一个
T. Baba | S. Ikeda | T. Ogura | E. Hagiwara | H. Kitamura | A. Sekine | H. Okabayashi | T. Sakagami | T. Oda